Skip to main content
. 2016 Apr 27;41(10):2502–2511. doi: 10.1038/npp.2016.50

Table 2. Pathways Differentially Modulated at Baseline Between Patients Who Develop Depression Compared With Those Who Do Not (p⩽0.05).

Pathway Molecules
Ephrin B signaling GNAT2, NCK2, ROCK1, GNG2
Coagulation system A2M, PROS1, SERPIND1
G alpha q signaling RGS18, PPP3R1, ROCK1, GNG2
Ephrin receptor signaling GNAT2, NCK2, ROCK1, GNG2
NRF2-mediated oxidative stress response DNAJC8, DNAJA2, GSTM3, GPX2
Cardiac hypertrophy signaling PPP3R1, GNAT2, ROCK1, GNG2
CCR3 signaling in eosinophils PLA2G10, ROCK1, GNG2
Netrin signaling PPP3R1, NCK2
Axonal guidance signaling PPP3R1, GNAT2, NCK2, ROCK1, GNG2
CXCR4 signaling GNAT2, ROCK1, GNG2
Actin nucleation by ARP-WASP complex NCK2, ROCK1
Role of NFAT in regulation of the immune response PPP3R1, GNAT2, GNG2
RhoGDI signaling GNAT2, ROCK1, GNG2
Thrombin signaling GNAT2, ROCK1, GNG2
Integrin signaling NCK2, ROCK1, LIMS1
G Beta gamma signaling GNAT2, GNG2
Signalling by Rho family GTPases GNAT2, ROCK1, GNG2
IL-1 signaling GNAT2, GNG2
Phospholipase C signaling PPP3R1, PLA2G10, GNG2
fMLP signaling in neutrophils PPP3R1, GNG2
Androgen signalling GNAT2, GNG2
Extrinsic prothrombin activation pathway PROS1
Glutathione redox reactions I GPX2
Relaxin signaling GNAT2, GNG2